For Research Use Only Not For Human Consumption Proof, Not Promises Certificate of Analysis Purity 99.3% Labeled 10 mg Measured 10.21 mg Tested Apr 12, 2026 Lab: ILS Labs / Kovera Labs Plan Your Reconstitution Reconstitution Helper Auto-filled to the selected 10mg vial
In the Phase 2 clinical trial published in the New England Journal of Medicine (2023), participants receiving retatrutide achieved mean weight reductions of up to approximately 24% over 48 weeks
Alzheimers Drug Discovery Foundation
In this regard, as 15LO1 increased, GPX4 expression concomitantly increased to balance the high 15LO1 activity (Figure 2C)
Contact Genesis Lifestyle Medicine Today If you are ready to take control of your health and transform your life, contact Genesis Lifestyle Medicine today
Previous allergic reactions to medications, particularly other injectable therapies or peptide-based drugs, represent the most significant risk factor